241 related articles for article (PubMed ID: 21924676)
1. Family history and herpes zoster risk in the era of shingles vaccination.
Hernandez PO; Javed S; Mendoza N; Lapolla W; Hicks LD; Tyring SK
J Clin Virol; 2011 Dec; 52(4):344-8. PubMed ID: 21924676
[TBL] [Abstract][Full Text] [Related]
2. Family history as a risk factor for herpes zoster: a case-control study.
Hicks LD; Cook-Norris RH; Mendoza N; Madkan V; Arora A; Tyring SK
Arch Dermatol; 2008 May; 144(5):603-8. PubMed ID: 18490586
[TBL] [Abstract][Full Text] [Related]
3. No evidence of family history as a risk factor for herpes zoster in patients with post-herpetic neuralgia.
Gatti A; Pica F; Boccia MT; De Antoni F; Sabato AF; Volpi A
J Med Virol; 2010 May; 82(6):1007-11. PubMed ID: 20419815
[TBL] [Abstract][Full Text] [Related]
4. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination.
Civen R; Chaves SS; Jumaan A; Wu H; Mascola L; Gargiullo P; Seward JF
Pediatr Infect Dis J; 2009 Nov; 28(11):954-9. PubMed ID: 19536039
[TBL] [Abstract][Full Text] [Related]
5. Contacts with children and young people and adult risk of suffering herpes zoster.
Salleras M; Domínguez A; Soldevila N; Prat A; Garrido P; Torner N; Borrás E; Salleras L
Vaccine; 2011 Oct; 29(44):7602-5. PubMed ID: 21889558
[TBL] [Abstract][Full Text] [Related]
6. Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program.
Tanuseputro P; Zagorski B; Chan KJ; Kwong JC
Vaccine; 2011 Nov; 29(47):8580-4. PubMed ID: 21939721
[TBL] [Abstract][Full Text] [Related]
7. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
[TBL] [Abstract][Full Text] [Related]
8. Universal varicella vaccination: efficacy trends and effect on herpes zoster.
Goldman GS
Int J Toxicol; 2005; 24(4):205-13. PubMed ID: 16126614
[TBL] [Abstract][Full Text] [Related]
9. Zoster vaccine: current status and future prospects.
Oxman MN
Clin Infect Dis; 2010 Jul; 51(2):197-213. PubMed ID: 20550454
[TBL] [Abstract][Full Text] [Related]
10. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors.
Lu PJ; Euler GL; Jumaan AO; Harpaz R
Vaccine; 2009 Feb; 27(6):882-7. PubMed ID: 19071175
[TBL] [Abstract][Full Text] [Related]
11. Herpes zoster vaccine and the incidence of recurrent herpes zoster in an immunocompetent elderly population.
Tseng HF; Chi M; Smith N; Marcy SM; Sy LS; Jacobsen SJ
J Infect Dis; 2012 Jul; 206(2):190-6. PubMed ID: 22669900
[TBL] [Abstract][Full Text] [Related]
12. Risk factors of herpes zoster among children immunized with varicella vaccine: results from a nested case-control study.
Tseng HF; Smith N; Marcy SM; Sy LS; Chao CR; Jacobsen SJ
Pediatr Infect Dis J; 2010 Mar; 29(3):205-8. PubMed ID: 19952977
[TBL] [Abstract][Full Text] [Related]
13. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
[TBL] [Abstract][Full Text] [Related]
14. Herpes zoster: epidemiology, natural history, and common complications.
Weinberg JM
J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S130-5. PubMed ID: 18021864
[TBL] [Abstract][Full Text] [Related]
15. Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster.
Mills R; Tyring SK; Levin MJ; Parrino J; Li X; Coll KE; Stek JE; Schlienger K; Chan IS; Silber JL
Vaccine; 2010 Jun; 28(25):4204-9. PubMed ID: 20416263
[TBL] [Abstract][Full Text] [Related]
16. Why should older adults receive the shingles vaccine?
Harkness TL
J Gerontol Nurs; 2010 Oct; 36(10):51-5. PubMed ID: 20506935
[TBL] [Abstract][Full Text] [Related]
17. Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008.
Lu PJ; Euler GL; Harpaz R
Am J Prev Med; 2011 Feb; 40(2):e1-6. PubMed ID: 21238856
[TBL] [Abstract][Full Text] [Related]
18. Vaccination: a new option to reduce the burden of herpes zoster.
Mick G
Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716
[TBL] [Abstract][Full Text] [Related]
19. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
Betts RF
J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866
[TBL] [Abstract][Full Text] [Related]
20. Modelling the impact of varicella vaccination on varicella and zoster.
Karhunen M; Leino T; Salo H; Davidkin I; Kilpi T; Auranen K
Epidemiol Infect; 2010 Apr; 138(4):469-81. PubMed ID: 19796447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
